Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a

Area of Science:

• Hematology
• Genetics
• Rare Diseases

Background:

• Congenital dyserythropoietic anemias (CDAs) are inherited blood disorders.
• They are characterized by ineffective erythropoiesis, leading to anemia.
• CDA type 1b (CDA 1b) is the rarest and least understood subtype.

Purpose of the Study:

• To describe a case of CDA 1b in a child.
• To identify the genetic basis of the condition in this patient.
• To report the clinical manifestations and treatment response.

Main Methods:

• Clinical case presentation.
• Genetic analysis to identify gene mutation.
• Review of patient's medical history and treatment outcomes.

Main Results:

• A child presented with severe in utero and neonatal issues, limb anomalies, cardiac problems, vision impairment, short stature, and hip dysplasia.
• The patient had CDA 1b caused by a C15orf41 gene mutation.
• Anemia was complicated by iron overload and significant extramedullary erythropoiesis, causing skull deformities.

Conclusions:

• This case highlights the severe and multi-systemic manifestations of CDA 1b.
• C15orf41 gene mutations are implicated in CDA 1b.
• Pegylated interferon alfa-2a demonstrated efficacy in treating this rare condition.